Clinical Trials Browser

Adrenal Cortex Neoplasms × Pharmacogenomic Variants × Clear all

NCT03370718 2024-12-10

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Phase 2 Completed

18 enrolled 5 charts

Adrenal Cortex Neoplasms